June 10, 2013

Anglo-Swedish drug maker AstraZeneca will pay up to $1.15 billion for a U.S. developer of drugs for respiratory diseases, AstraZeneca said Monday.

June 5, 2013

Vidal Sassoon Pro Series is celebrating the 50th anniversary of the iconic bob hairstyle; the brand has launched the “Show Your Genius” Facebook contest.

May 29, 2013

British drug maker GlaxoSmithKline has acquired Swiss vaccine development company Okairos for $325 million, GSK said Wednesday.

May 28, 2013

After 50 years of service with the company, Kroger's mid-south division president John Hackett is retiring.

May 7, 2013

The global market for biosimilars will be worth nearly $2.5 billion this year, according to a new study.

April 22, 2013

Rumors are circulating that Amazon may be opening a brick-and-mortar store in London, according to published reports.

April 17, 2013

A Food and Drug Administration panel has recommended that the agency approve an experimental drug for chronic obstructive pulmonary disease made by GlaxoSmithKline and Theravance, the two companies said.

April 5, 2013

GlaxoSmithKline has started a late-stage clinical trial of a drug in patients with an inflammatory disease that affects the blood vessels.

March 27, 2013

Alliance Boots on Wednesday announced its contract manufacturing business BCM will invest heavier into core competency categories, such as beauty and skin care, as it discontinues third-party manufacturer development in unnamed "unprofitable" categories.

March 25, 2013

The U.K.'s Infirst Healthcare on Monday announced it has successfully raised $32.1 million in new funds.

March 15, 2013

MinuteClinic president and SVP/associate chief medical officer of CVS Caremark, Andrew Sussman, attended two separate healthcare events in London last week to discuss how MinuteClinic is improving care and access at substantially lower cost.

This is important because, regardless of whether a country has universal healthcare or not, someone has to pay for it and accessibility can still be an issue. Interestingly, a British supermarket began testing the concept of an in-store physician-staffed clinic back in 2008 in an effort to improve access. 
A key reason: Its supermarkets are often situated in a convenient location with public transport links and ample parking.

March 14, 2013

MinuteClinic president and SVP/associate chief medical officer of CVS Caremark, Andrew Sussman, traveled to London this week to discuss how MinuteClinic is improving care and access at substantially lower cost, the company has announced.

February 28, 2013

The world market for generic drugs will jump more than 15% this year and reach a global total of $127.8 billion, predicted a report from British market research firm Visiongain.

February 19, 2013

The Food and Drug Administration has granted priority review to an experimental drug made by ViiV Healthcare for HIV, the company, a joint venture between British drug maker GlaxoSmithKline and American drug maker Pfizer, announced.

February 13, 2013

Walgreens and Alliance Boots will generate $130 billion or more in combined sales, Greg Wasson, Walgreens president and CEO told analysts Wednesday.

February 12, 2013

Putney has launched a generic version of a veterinary skin infection drug, the company said.

January 30, 2013

A ban on importing and selling animal-tested cosmetics products and ingredients will enter into force in March. The ban affects all cosmetics, including toiletries and beauty products.

January 21, 2013

Drug maker GlaxoSmithKline is seeking Food and Drug Administration approval for a new treatment for Type 2 diabetes, the drug maker said.

January 7, 2013

Lingering fears of pandemic flu in the United States and a spike in flu activity will help to keep vaccination levels high, according to a new report.

December 18, 2012

The Food and Drug Administration has approved a new four-strain flu vaccine made by GlaxoSmithKline, the drug maker said.

December 17, 2012

The Food and Drug Administration has approved a new biotech drug from GlaxoSmithKline for anthrax, the drug maker said.

November 29, 2012

The global market for generic drugs will reach more than $125 billion next year, according to a new report by a British market-research firm.

November 28, 2012

Revlon is inviting beauty enthusiasts and fashion fanatics to experience a one-of-a-kind exhibition that will guide them through iconic moments in Revlon's history that have contributed to shaping the brand as we see it today.

November 19, 2012

The Food and Drug Administration has approved a drug for a condition that can complicate treatment for hepatitis C.